{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:12:03Z","timestamp":1792800723746,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Young Research Fund Project of the Cancer Hospital of Shantou University Medical College","award":["No. 2023A002"],"award-info":[{"award-number":["No. 2023A002"]}],"id":[{"id":"https:\/\/ror.org\/00a53nq42","id-type":"ROR","asserted-by":"crossref"}]},{"name":"2023 Science and Technology Innovation Strategy Project of Guangdong Province (Big Project + Task List), China","award":["No. STKJ2023009,20230403"],"award-info":[{"award-number":["No. STKJ2023009,20230403"]}]},{"name":"the Bethune\u201cWings for Research\u201d-Supporting Research Projects in the Field of Therapeutics, China","award":["No. 2024-YJ-154-S-016"],"award-info":[{"award-number":["No. 2024-YJ-154-S-016"]}]},{"name":"the Science and Technology Project of Shantou, China","award":["No. 200601155261085"],"award-info":[{"award-number":["No. 200601155261085"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04210-z","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:05:36Z","timestamp":1770163536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anatomical location of metastatic sentinel lymph node and clinicopathological characteristics for predicting risk of non-sentinel lymph node metastasis"],"prefix":"10.1186","volume":"24","author":[{"given":"Qunchen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfa","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangshen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huancheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jundong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"4210_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.20892\/j.issn.2095-3941.2018.0023","volume":"15","author":"A Maimaitiaili","year":"2018","unstructured":"Maimaitiaili A, Wu D, Liu Z, Liu H, Muyiduli X, Fan Z. Analysis of factors related to non-sentinel lymph node metastasis in 296 Sentinel lymph node-positive Chinese breast cancer patients. Cancer Biol Med. 2018;15:282\u20139.","journal-title":"Cancer Biol Med"},{"key":"4210_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10549-012-2219-x","volume":"135","author":"JY Chen","year":"2012","unstructured":"Chen JY, Chen JJ, Yang BL, Liu ZB, Huang XY, Liu GY, et al. Predicting Sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram. Breast Cancer Res Treat. 2012;135:839\u201348.","journal-title":"Breast Cancer Res Treat"},{"key":"4210_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2407-8-66","volume":"8","author":"HE Kohrt","year":"2008","unstructured":"Kohrt HE, Olshen RA, Bermas HR, Goodson WH, Wood DJ, Henry S, et al. New models and online calculator for predicting non-sentinel lymph node status in Sentinel lymph node positive breast cancer patients. BMC Cancer. 2008;8:66.","journal-title":"BMC Cancer"},{"key":"4210_CR4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/jjco\/hys150","volume":"42","author":"PF Qiu","year":"2012","unstructured":"Qiu PF, Liu JJ, Wang YS, Yang GR, Liu YB, Sun X, et al. Risk factors for Sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients. Jpn J Clin Oncol. 2012;42:1002\u20137.","journal-title":"Jpn J Clin Oncol"},{"key":"4210_CR5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejso.2011.01.006","volume":"37","author":"RF van la Parra","year":"2011","unstructured":"van la Parra RF, Peer PG, Ernst MF, Bosscha K. Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN. Eur J Surg Oncol. 2011;37:290\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"4210_CR6","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","volume":"19","author":"V Galimberti","year":"2018","unstructured":"Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23\u2009\u2013\u200901): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19:1385\u201393.","journal-title":"Lancet Oncol"},{"key":"4210_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1055\/s-0040-1712125","volume":"42","author":"FP Cavalcante","year":"2020","unstructured":"Cavalcante FP, Millen EC, Zerwes FP, Novita GG. Progress in local treatment of breast cancer: A narrative review. Rev Bras Ginecol Obstet. 2020;42:356\u201364.","journal-title":"Rev Bras Ginecol Obstet"},{"key":"4210_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","volume":"95","author":"A Fleissig","year":"2006","unstructured":"Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing Sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95:279\u201393.","journal-title":"Breast Cancer Res Treat"},{"key":"4210_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, et al. Locoregional recurrence after Sentinel lymph node dissection with or without axillary dissection in patients with Sentinel lymph node metastases: Long-term Follow-up from the American college of surgeons oncology group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg. 2016;264:413\u201320.","journal-title":"Ann Surg"},{"key":"4210_CR10","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of axillary dissection vs no axillary dissection on 10-Year overall survival among women with invasive breast cancer and Sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318:918\u201326.","journal-title":"JAMA"},{"key":"4210_CR11","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive Sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303\u201310.","journal-title":"Lancet Oncol"},{"key":"4210_CR12","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","volume":"43","author":"\u00c1 S\u00e1volt","year":"2017","unstructured":"S\u00e1volt \u00c1, P\u00e9ley G, Polg\u00e1r C, Udvarhelyi N, Rubovszky G, Kov\u00e1cs E, et al. Eight-year follow up result of the OTOASOR trial: the optimal treatment of the Axilla - Surgery or radiotherapy after positive Sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol. 2017;43:672\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"4210_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10549-021-06274-9","volume":"189","author":"C Ortega Exp\u00f3sito","year":"2021","unstructured":"Ortega Exp\u00f3sito C, Falo C, Pernas S, P\u00e9rez Carton S, Gil Gil M, Ortega R, et al. The effect of omitting axillary dissection and the impact of radiotherapy on patients with breast cancer Sentinel node macrometastases: a cohort study following the ACOSOG Z0011 and AMAROS trials. Breast Cancer Res Treat. 2021;189:111\u201320.","journal-title":"Breast Cancer Res Treat"},{"key":"4210_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1415369","volume":"373","author":"PM Poortmans","year":"2015","unstructured":"Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317\u201327.","journal-title":"N Engl J Med"},{"key":"4210_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMoa1415340","volume":"373","author":"TJ Whelan","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional nodal irradiation in Early-Stage breast cancer. N Engl J Med. 2015;373:307\u201316.","journal-title":"N Engl J Med"},{"key":"4210_CR16","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","volume":"10","author":"KJ Van Zee","year":"2003","unstructured":"Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive Sentinel node biopsy. Ann Surg Oncol. 2003;10:1140\u201351.","journal-title":"Ann Surg Oncol"},{"key":"4210_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/bjs.5943","volume":"95","author":"A Pal","year":"2008","unstructured":"Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD. A model for predicting non-sentinel lymph node metastatic disease when the Sentinel lymph node is positive. Br J Surg. 2008;95:302\u20139.","journal-title":"Br J Surg"},{"key":"4210_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10549-004-5781-z","volume":"91","author":"E Barranger","year":"2005","unstructured":"Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with Sentinel lymph node involvement. Breast Cancer Res Treat. 2005;91:113\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"4210_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1245\/ASO.2003.05.020","volume":"10","author":"RF Hwang","year":"2003","unstructured":"Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003;10:248\u201354.","journal-title":"Ann Surg Oncol"},{"key":"4210_CR20","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1007\/s00268-015-3189-z","volume":"39","author":"JY Chen","year":"2015","unstructured":"Chen JY, Chen JJ, Xue JY, Chen Y, Liu GY, Han QX, et al. Predicting Non-sentinel lymph node metastasis in a Chinese breast cancer population with 1\u20132 positive Sentinel nodes: development and assessment of a new predictive nomogram. World J Surg. 2015;39:2919\u201327.","journal-title":"World J Surg"},{"key":"4210_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.6004\/jnccn.2017.0044","volume":"15","author":"WJ Gradishar","year":"2017","unstructured":"Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, et al. NCCN guidelines insights: breast Cancer, version 1.2017. J Natl Compr Canc Netw. 2017;15:433\u201351.","journal-title":"J Natl Compr Canc Netw"},{"key":"4210_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1245\/s10434-008-0229-z","volume":"16","author":"G Gill","year":"2009","unstructured":"Gill G. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of Sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol. 2009;16:266\u201375.","journal-title":"Ann Surg Oncol"},{"key":"4210_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10549-006-9192-1","volume":"99","author":"A Goyal","year":"2006","unstructured":"Goyal A, Newcombe RG, Chhabra A, Mansel RE. Factors affecting failed localisation and false-negative rates of Sentinel node biopsy in breast cancer\u2013results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99:203\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"4210_CR24","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1470-2045(06)70947-0","volume":"7","author":"U Veronesi","year":"2006","unstructured":"Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol. 2006;7:983\u201390.","journal-title":"Lancet Oncol"},{"key":"4210_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/SLA.0b013e31812e6a73","volume":"247","author":"G Zavagno","year":"2008","unstructured":"Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, et al. A randomized clinical trial on Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella\/GIVOM trial. Ann Surg. 2008;247:207\u201313.","journal-title":"Ann Surg"},{"key":"4210_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881\u20138.","journal-title":"Lancet Oncol"},{"key":"4210_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5152\/ejbh.2020.5332","volume":"16","author":"H Ata\u015f","year":"2020","unstructured":"Ata\u015f H, Altun \u00d6zdemir B, Menek\u015fe E, \u00d6zden S, Y\u00fcksek YN, Da\u011flar G. Associated features with Non-Sentinel lymph node involvement in early stage breast cancer patients who have positive macrometastatic Sentinel lymph node. Eur J Breast Health. 2020;16:192\u20137.","journal-title":"Eur J Breast Health"},{"key":"4210_CR28","doi-asserted-by":"publisher","first-page":"7704686","DOI":"10.1155\/2022\/7704686","volume":"2022","author":"L He","year":"2022","unstructured":"He L, Liang P, Zeng H, Huang G, Wu J, Zhang Y, et al. A predictive model for nonsentinel node status after Sentinel lymph node biopsy in Sentinel lymph node-Positive Chinese women with early breast cancer. J Oncol. 2022;2022:7704686.","journal-title":"J Oncol"},{"key":"4210_CR29","doi-asserted-by":"publisher","first-page":"153303381878503","DOI":"10.1177\/1533033818785032","volume":"17","author":"P Wu","year":"2018","unstructured":"Wu P, Zhao K, Liang Y, Ye W, Liu Z, Liang C. Validation of breast cancer models for predicting the nonsentinel lymph node metastasis after a positive Sentinel lymph node biopsy in a Chinese population. Technol Cancer Res Treat. 2018;17:1533033818785032.","journal-title":"Technol Cancer Res Treat"},{"key":"4210_CR30","doi-asserted-by":"publisher","first-page":"8675705","DOI":"10.1155\/2022\/8675705","volume":"2022","author":"X Zeng","year":"2022","unstructured":"Zeng X, Li Y, Sun C, Liu Z, Zhao J, Ma X, et al. A new model for predicting nonsentinel lymph node metastasis in Early-Stage breast cancer using MMP15. J Oncol. 2022;2022:8675705.","journal-title":"J Oncol"},{"key":"4210_CR31","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1245\/s10434-018-7059-4","volume":"26","author":"SE Tevis","year":"2019","unstructured":"Tevis SE, Bassett R, Bedrosian I, Barcenas CH, Black DM, Caudle AS, et al. OncotypeDX recurrence score does not predict nodal burden in clinically node negative breast cancer patients. Ann Surg Oncol. 2019;26:815\u201320.","journal-title":"Ann Surg Oncol"},{"key":"4210_CR32","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1245\/s10434-014-4269-2","volume":"22","author":"H Shigematsu","year":"2015","unstructured":"Shigematsu H, Taguchi K, Koui H, Ohno S. Clinical significance of extracapsular invasion at Sentinel lymph nodes in breast cancer patients with Sentinel lymph node involvement. Ann Surg Oncol. 2015;22:2365\u201371.","journal-title":"Ann Surg Oncol"},{"key":"4210_CR33","doi-asserted-by":"publisher","first-page":"14684","DOI":"10.1038\/s41598-020-71594-7","volume":"10","author":"X Yang","year":"2020","unstructured":"Yang X, Ma X, Yang W, Shui R. Clinical significance of extranodal extension in Sentinel lymph node positive breast cancer. Sci Rep. 2020;10:14684.","journal-title":"Sci Rep"},{"key":"4210_CR34","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1245\/s10434-014-3752-0","volume":"21","author":"J Gooch","year":"2014","unstructured":"Gooch J, King TA, Eaton A, Dengel L, Stempel M, Corben AD, et al. The extent of extracapsular extension May influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer. Ann Surg Oncol. 2014;21:2897\u2013903.","journal-title":"Ann Surg Oncol"},{"key":"4210_CR35","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1200\/JCO.2007.11.9479","volume":"26","author":"A Katz","year":"2008","unstructured":"Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, et al. Nomogram for the prediction of having four or more involved nodes for Sentinel lymph node-positive breast cancer. J Clin Oncol. 2008;26:2093\u20138.","journal-title":"J Clin Oncol"},{"key":"4210_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.breast.2020.08.001","volume":"53","author":"Z Yang","year":"2020","unstructured":"Yang Z, Lan X, Huang Z, Yang Y, Tang Y, Jing H, et al. Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive Sentinel lymph nodes. Breast. 2020;53:143\u201351.","journal-title":"Breast"},{"key":"4210_CR37","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ijrobp.2008.12.028","volume":"75","author":"B Unal","year":"2009","unstructured":"Unal B, Gur AS, Beriwal S, Tang G, Johnson R, Ahrendt G, et al. Predicting likelihood of having four or more positive nodes in patient with Sentinel lymph node-positive breast cancer: a nomogram validation study. Int J Radiat Oncol Biol Phys. 2009;75:1035\u201340.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4210_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4048\/jbc.2017.20.3.270","volume":"20","author":"I Kim","year":"2017","unstructured":"Kim I, Ryu JM, Kim JM, Choi HJ, Lee SK, Yu JH, et al. Development of a nomogram to predict N2 or N3 stage in T1-2 invasive breast cancer patients with no palpable lymphadenopathy. J Breast Cancer. 2017;20:270\u20138.","journal-title":"J Breast Cancer"},{"key":"4210_CR39","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3760\/cma.j.issn.0366-6999.20122546","volume":"126","author":"B Yang","year":"2013","unstructured":"Yang B, Yang L, Zuo WS, Ge WK, Zheng G, Zheng MZ, et al. Predictors to assess non-sentinel lymph node status in breast cancer patients with only one Sentinel lymph node metastasis. Chin Med J (Engl). 2013;126:476\u201381.","journal-title":"Chin Med J (Engl)"},{"key":"4210_CR40","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1524-4741.2008.00646.x","volume":"14","author":"H Jinno","year":"2008","unstructured":"Jinno H, Sakata M, Asaga S, Wada M, Shimada T, Kitagawa Y, et al. Predictors to assess non-sentinel lymph node status in breast cancer patients with Sentinel lymph node metastasis. Breast J. 2008;14:551\u20135.","journal-title":"Breast J"},{"key":"4210_CR41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.breast.2014.03.009","volume":"23","author":"A Reynders","year":"2014","unstructured":"Reynders A, Brouckaert O, Smeets A, Laenen A, Yoshihara E, Persyn F, et al. Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive Sentinel lymph node. Breast. 2014;23:453\u20139.","journal-title":"Breast"},{"key":"4210_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jnci.2011.12.004","volume":"24","author":"H Eldweny","year":"2012","unstructured":"Eldweny H, Alkhaldy K, Alsaleh N, Abdulsamad M, Abbas A, Hamad A, et al. Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive Sentinel lymph node (Pilot study). J Egypt Natl Canc Inst. 2012;24:23\u201330.","journal-title":"J Egypt Natl Canc Inst"},{"key":"4210_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u2009\u2013\u200901): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297\u2013305.","journal-title":"Lancet Oncol"},{"key":"4210_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","volume":"20","author":"M Sol\u00e1","year":"2013","unstructured":"Sol\u00e1 M, Alberro JA, Fraile M, Santesteban P, Ramos M, Fabregas R, et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with Sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000. Ann Surg Oncol. 2013;20:120\u20137.","journal-title":"Ann Surg Oncol"},{"key":"4210_CR45","doi-asserted-by":"publisher","first-page":"712","DOI":"10.4236\/jct.2012.325090","volume":"3","author":"TA Baker","year":"2012","unstructured":"Baker TA, Wadhwani N, Rajan P, Shoup M, Neveu M, Mattix-Kramer H, et al. The size of metastasis in the Sentinel node is a predictor of additional non-sentinel node positivity. J Cancer Ther. 2012;3:712\u20137.","journal-title":"J Cancer Ther"},{"key":"4210_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/SLA.0b013e318238f461","volume":"255","author":"EA Mittendorf","year":"2012","unstructured":"Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, et al. Incorporation of Sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive Sentinel lymph node. Ann Surg. 2012;255:109\u201315.","journal-title":"Ann Surg"},{"key":"4210_CR47","first-page":"279013","volume":"2013","author":"J Li","year":"2013","unstructured":"Li J, Zhang Y, Zhang W, Jia S, Gu X, Ma Y, et al. Intercostobrachial nerves as a novel anatomic landmark for dividing the axillary space in lymph node dissection. ISRN Oncol. 2013;2013:279013.","journal-title":"ISRN Oncol"},{"key":"4210_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12893-015-0067-4","volume":"15","author":"J Li","year":"2015","unstructured":"Li J, Jia S, Zhang W, Qiu F, Zhang Y, Gu X, et al. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements Sentinel node biopsy in patients with clinically node-negative breast cancer. BMC Surg. 2015;15:79.","journal-title":"BMC Surg"},{"key":"4210_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/1477-7819-12-290","volume":"12","author":"W Guo","year":"2014","unstructured":"Guo W, Zhang L, Ji J, Gao W, Liu J, Tong M. Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for Sentinel lymph node biopsy in patients with breast cancer. World J Surg Oncol. 2014;12:290.","journal-title":"World J Surg Oncol"},{"key":"4210_CR50","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/cancers14040888","volume":"14","author":"M Coibion","year":"2022","unstructured":"Coibion M, Olivier F, Courtois A, Maes N, Jossa V, Jerusalem G. A randomized prospective non-inferiority trial of Sentinel lymph node biopsy in early breast cancer: blue dye compared with indocyanine green fluorescence tracer. Cancers (Basel). 2022;14:888.","journal-title":"Cancers (Basel)"},{"key":"4210_CR51","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.21037\/gs-22-434","volume":"11","author":"Y Xu","year":"2022","unstructured":"Xu Y, Yuan S, Chen M, Gong K, Liu Y, Li S, et al. Evaluation of indocyanine green combined with methylene blue staining in Sentinel lymph node biopsy of breast cancer. Gland Surg. 2022;11:1489\u201396.","journal-title":"Gland Surg"},{"key":"4210_CR52","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.asjsur.2020.02.003","volume":"43","author":"J Lin","year":"2020","unstructured":"Lin J, Lin LS, Chen DR, Lin KJ, Wang YF, Chang YJ. Indocyanine green fluorescence method for Sentinel lymph node biopsy in breast cancer. Asian J Surg. 2020;43:1149\u201353.","journal-title":"Asian J Surg"},{"key":"4210_CR53","first-page":"487","volume":"8","author":"X Bi","year":"2015","unstructured":"Bi X, Wang Y, Li M, Chen P, Zhou Z, Liu Y, et al. Validation of the memorial sloan kettering cancer center nomogram for predicting non-sentinel lymph node metastasis in Sentinel lymph node-positive breast-cancer patients. Onco Targets Ther. 2015;8:487\u201393.","journal-title":"Onco Targets Ther"},{"key":"4210_CR54","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jamcollsurg.2008.10.029","volume":"208","author":"AS Gur","year":"2009","unstructured":"Gur AS, Unal B, Johnson R, Ahrendt G, Bonaventura M, Gordon P, et al. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive Sentinel node biopsy. J Am Coll Surg. 2009;208:229\u201335.","journal-title":"J Am Coll Surg"},{"key":"4210_CR55","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.amjsurg.2005.06.008","volume":"190","author":"AC Degnim","year":"2005","unstructured":"Degnim AC, Reynolds C, Pantvaidya G, Zakaria S, Hoskin T, Barnes S, et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg. 2005;190:543\u201350.","journal-title":"Am J Surg"},{"key":"4210_CR56","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1245\/s10434-008-9993-z","volume":"15","author":"J Cho","year":"2008","unstructured":"Cho J, Han W, Lee JW, Ko E, Kang SY, Jung SY, et al. A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic Sentinel lymph nodes: a comparison with other scoring systems. Ann Surg Oncol. 2008;15:2278\u201386.","journal-title":"Ann Surg Oncol"},{"key":"4210_CR57","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejso.2009.05.007","volume":"36","author":"AS Gur","year":"2010","unstructured":"Gur AS, Unal B, Ozbek U, Ozmen V, Aydogan F, Gokgoz S, et al. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive Sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol. 2010;36:30\u20135.","journal-title":"Eur J Surg Oncol"},{"key":"4210_CR58","first-page":"941","volume":"53","author":"J Huang","year":"2015","unstructured":"Huang J, Chen X, Fei X, Huang O, Wu J, Zong Y, et al. [Risk factors of non-sentinel lymph node metastasis and performance of the MSKCC nomogram in breast cancer patients with metastatic Sentinel lymph node]. Zhonghua Wai Ke Za Zhi. 2015;53:941\u20136. [in Chinese].","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"4210_CR59","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s12253-009-9177-6","volume":"15","author":"O Coufal","year":"2009","unstructured":"Coufal O, Pavl\u00edk T, Fabian P, Bori R, Boross G, Sejben I, et al. Predicting non-sentinel lymph node status after positive Sentinel biopsy in breast cancer: what model performs the best in a Czech population. Pathol Oncol Res. 2009;15:733\u201340.","journal-title":"Pathol Oncol Res"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04210-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04210-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04210-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:03:03Z","timestamp":1772629383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04210-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4210"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04210-z","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Cancer Hospital of Shantou University Medical College (NO. 2023086), and informed consents were obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}